John Brancaccio

John Patrick Brancaccio currently serves as Independent Non-Executive Director at OKYO Pharma Ltd. since 2020, Director at FermaVir Pharmaceuticals LLC since 2005, Independent Director at Actavia Life Sciences, Inc. since 2016, Independent Non-Executive Director at AccuStem Sciences, Inc. since 2021, Independent Non-Executive Director at Tiziana Life Sciences Ltd. (Bermuda) since 2020, and Non-Executive Director at Tiziana Life Sciences Ltd. (United Kingdom).
Former roles include Chairman & Chief Financial Officer at Hepion Pharmaceuticals, Inc. from 2013 to 2025, Independent Director at Callisto Pharmaceuticals, Inc. from 2004 to 2013, Director at Pawfect Foods, Inc., Director at Active With Me, Inc., Independent Director at Cardiff Oncology, Inc. from 2005 to 2022, Independent Director at Synergy Pharmaceuticals LLC from 2008 to 2019, Director at Tamir Biotechnology, Inc. from 2004 to 2019, Director at Rasna Therapeutics, Inc. in 2016, Chief Financial & Operating Officer at Eline Entertainment Group, Inc. from 2000 to 2002, Chief Financial Officer, Secretary & Treasurer at Memory Pharmaceuticals Corp.
from 2002 to 2004, Chief Financial Officer at Orchestra Medical Ventures LLC, and Chief Financial Officer at Accelerated Technologies, Inc. from 2004 to 2017.
Education includes undergraduate studies at Seton Hall University.